Detalhe da pesquisa
1.
Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.
Clin Cancer Res
; 25(1): 290-299, 2019 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30279232